SUBSCRIBE
SUBSCRIBE

Zealand Pharma to Present at Upcoming Global Healthcare and Midcap Investor Conferences

December 13, 2012 | 
1 min read

Copenhagen, 2012-12-13 13:22 CET (GLOBE NEWSWIRE) -- Zealand Pharma (NASDAQ OMX Copenhagen: ZEAL) announces that the company’s management will give a corporate presentation at the following upcoming investor conferences:

Events Europe
MORE ON THIS TOPIC
Dorval, Quebec, Canada - September 3, 2021: Novartis Pharmaceuticals Canada Inc. head office building in Dorval, Quebec, Canada. Novartis is a global healthcare company based in Switzerland.
Spinal muscular atrophy
Novartis’ Intrathecal Zolgensma Effective in Older Children
March 19, 2025
 · 
6 min read
 · 
Heather McKenzie
Contemporary art collage showing a hand giving a thumbs down surrounded by red arrows pointing down, concept of negative feedback and bad review
Regulatory
Biogen, Eisai’s Leqembi Suffers Overseas Setbacks as UK Denies Coverage, Australia Denies Approval
March 7, 2025
 · 
2 min read
 · 
Tristan Manalac
The EMA's former headquarters in London
Europe
Biogen, Eisai Continue Leqembi’s European Rally as CHMP Reaffirms Positive Opinion
March 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Editorial
Transparency Missing in Action at HHS Despite Leaders’ Calls for Clarity
February 28, 2025
 · 
4 min read
 · 
Heather McKenzie